title: Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus-related cirrhosis.
authors.forename: Paul Y
authors.initials: PY
authors.lastname: Kwo
authors.forename: A Joseph
authors.initials: AJ
authors.lastname: Tector
mesh_terms: D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D058625:End Stage Liver Disease / Q000628:therapy; D005838:Genotype; D016174:Hepacivirus; D006526:Hepatitis C / Q000150:complications* / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy*; D017093:Liver Failure / Q000150:complications* / Q000628:therapy; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D012367:RNA, Viral / Q000032:analysis; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral